Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayFeb 05, 2021 10:12 am

NetworkNewsBreaks – Paltalk Inc (PALT) Featured by M-Vest

Paltalk (OTCQB: PALT), a communications software innovator, was recently highlighted as a featured company by M-Vest. The business description reads, “Paltalk operates a leading network of consumer applications that the company believes create a unique social media enterprise where users can meet, see, chat, broadcast and message in real time in a secure environment with others in the network. Paltalk's consumer applications generate revenue principally from recurring subscription fees, including sale of virtual gifts and advertising arrangements.” For more details, visit https://nnw.fm/b4USz About Paltalk Inc. Paltalk is a communications software innovator that powers multimedia social applications. Its product portfolio includes…

Continue Reading

FridayFeb 05, 2021 10:11 am

NetworkNewsBreaks – Intec Pharma Ltd. (NASDAQ: NTEC) Featured by M-Vest

Intec Pharma (NASDAQ: NTEC), a clinical-stage biopharmaceutical company, was recently highlighted as a featured company by M-Vest. The business description reads, “Intec’s strategy is to leverage its proprietary delivery technology to improve the properties of known/approved compounds. Intec also plans to work in collaboration with biotechnology and pharmaceutical companies to develop novel delivery systems for their proprietary drugs, including existing compounds undergoing lifecycle management.” For more details, visit https://nnw.fm/Sd1jP About Intec Pharma Ltd. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill(R) platform technology. The company's Accordion Pill is an oral drug…

Continue Reading

FridayFeb 05, 2021 10:04 am

NetworkNewsBreaks – Heritage Global Inc. (NASDAQ: HGBL) Featured by M-Vest

Heritage Global (NASDAQ: HGBL), an asset services company, was recently highlighted as a featured company by M-Vest. The business description reads, “Heritage Global Inc. (NASDAQ: HGBL) (‘Heritage Global’ or the ‘Company’) started in February 2009 to operate in the industrial liquidation and valuation business. Heritage Global has specialized in transactions involving intact, turnkey manufacturing plants – typically arising from bankruptcies, corporate restructuring and plant closures. The Company arranged traditional asset disposition sales, including liquidation and auctions, and subsequently expanded into real estate auctions, asset and inventory valuations, financial asset auctions, intellectual property auctions, distressed asset advisory and asset-based lending.” For…

Continue Reading

FridayFeb 05, 2021 9:52 am

NetworkNewsBreaks – AlgoTrader Offers ‘Best of Both Worlds’ by Combining Quantitative Analysis with Human Expertise

AlgoTrader blurs the line between the data-driven strategies of quants and the fundamental approach that many discretionary traders take. This hybrid, or quantamental, approach integrates automation, quantitative techniques and alternative data sources with the ability for human stock pickers to make the final decision about executing trades. For traders looking for this “best of both worlds” solution, identifying the core competencies of humans while automating routine tasks such as compliance, monitoring and record-keeping is essential — and often comes down to choosing the right order and execution management system (“OEMS”). An integrated OEMS allows traders to simplify their workflow by…

Continue Reading

FridayFeb 05, 2021 9:21 am

NetworkNewsBreaks – Adial Pharmaceuticals Inc (NASDAQ: ADIL) Featured by M-Vest

Adial Pharmaceuticals (NASDAQ: ADIL), a clinical-stage biopharmaceutical company, was recently highlighted as a featured company by M-Vest. The update reads, “Adial has created an investigational attendant diagnostic biomarker blood test for the genetic screening of patients with certain biomarkers that, as reported in the American Journal of Psychiatry (Johnson, et. al. 2011 & 2013), Adial believes make patients more likely to benefit from treatment with AD04. Adial’s strategy is to integrate pre-treatment genetic screening into AD04’s label to create a patient-specific treatment in one integrated therapeutic offering. Adial’s goal is to develop a genetically targeted, effective and safe product candidate…

Continue Reading

FridayFeb 05, 2021 9:02 am

NetworkNewsBreaks – Square Inc. (NYSE: SQ) Featured in Analysis Report

Square (NYSE: SQ), a cohesive commerce ecosystem that helps sellers start, run and grow their business, was featured in a recent LikeFolio analysis report that discussed an increase in consumer demand for the company. The report, written by LikeFolio Founder Andy Swan, reads, “Square is buzzing -- alongside other crypto-involved names. This makes sense. After all, SQ holds a significant volume of Bitcoin on its balance sheet and has enabled consumers to buy and sell the cryptocurrency on its Cash App platform since early 2018. And take a look at SQ mentions... Square mentions increased +131% YoY in the past…

Continue Reading

ThursdayFeb 04, 2021 3:24 pm

NetworkNewsBreaks – CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, believes that its proprietary CiBiDinol technology will be a game-changer. According to a recent article, “the company believes that the amount of CBD needed to achieve the targeted therapeutic effects can be reduced significantly, resulting in reduced costs for both manufacturers and consumers.” CBD-based products “reduce inflammation while providing pain relief.” They are also the preferred option because they are “a gentler way to relieve pain and reduce inflammation,” unlike mainstream pharmaceuticals that have dangerous toxicity levels. CiBiDinol’s high efficacy per dose was the subject of “testing conducted via third-party services…

Continue Reading

ThursdayFeb 04, 2021 3:01 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) on the Verge of Changing History with Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, has set sights on an encouraging future for glioblastoma patients with its upcoming Phase 2 trial of Berubicin. The article detailing this groundbreaking news quoted the company’s CEO John Climaco as saying, “Anthracyclines as a class of chemotherapy have been used for over 60 years to treat a variety of cancers… However, historically, anthracyclines have never been used to treat primary or metastatic brain cancers because scientists could not demonstrate that anthracyclines were able…

Continue Reading

ThursdayFeb 04, 2021 2:40 pm

NetworkNewsBreaks – Gage Cannabis Co. Poised Amid Michigan’s 1st Anniversary of Recreational Marijuana Sales

Gage Cannabis, a leading vertically integrated cannabis operator currently focused exclusively on the Michigan market, is positioned for opportunity after the state recently celebrated its one-year anniversary of the legalization of recreational marijuana. A recent article discussing this reads, “Gage Cannabis has been able to partake in the region’s rapid growth trajectory as a by-product of the company’s aggressive expansion plan – one that has seen the opening of six medical or adult-use locations across the state, with a further 10+ locations slated to open in 2021. The company has also announced its intentions to raise up to $50 million…

Continue Reading

ThursdayFeb 04, 2021 2:07 pm

NetworkNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Builds on Success, Launches into 2021 with Exciting Projects

Pac Roots (CSE: PACR), an innovative genetics-based cannabis company located in Canada, recently provided an update to investors and stakeholders following the first hemp harvest on its 100-acre site situated in British Columbia’s South Okanagan Valley. Pac Roots announced the remarkable success of its initial harvest, which yielded a quality far higher than expected. The company also announced that it would process and sell the entire >105,000-pound biomass to Speakeasy Cannabis Club (CSE: EASY).  A recent article covered this as well as the company’s low-cost production capabilities, which Pac Roots believes provide a sustainable competitive advantage and the ability to…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000